Sweden· SE-20001228000012
TRIZIVIR 300 mg/150 mg/300 mg Filmdragerad tablett
A medicinal product containing zidovudine + abacavir sulfate + lamivudine, registered in Sweden by ViiV Healthcare BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Zidovudine + Abacavir Sulfate + Lamivudine
- Manufacturer
- ViiV Healthcare BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20001228000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zidovudine + abacavir sulfate + lamivudine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRIZIVIRViiV Healthcare BV, Amersfoort
- SpainTRIZIVIR 300 MG/150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- FranceABACAVIR/LAMIVUDINE/ZIDOVUDINE VIATRIS 300 mg/150 mg/300 mg, comprimé pelliculéVIATRIS SANTE
- IrelandTrizivir 300 mg/150 mg/300 mg film-coated tabletsViiV Healthcare BV
- NetherlandsAbacavir/Lamivudine/Zidovudine Mylan 300 mg/150 mg/300 mg filmomhulde tablettenMylan Pharmaceuticals Limited
- FinlandTRIZIVIRViiV Healthcare BV
- IcelandTrizivirViiV Healthcare BV
- United StatesABACAVIR, LAMIVUDINE AND ZIDOVUDINELupin Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- France · Abacavir/Lamivudine/Zidovudine Viatris
- Iceland · Trizivir
- Italy · Abacavir/Lamivudina/Zidovudina Mylan
- Liechtenstein · Trizivir
- Netherlands · Abacavir/Lamivudine/Zidovudine Mylan
- Norway · Trizivir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e5bdf24-83b0-4664-9880-9b972e97a417 GET /v1/drugs/2e5bdf24-83b0-4664-9880-9b972e97a417?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20001228000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20001228000012",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/trizivir-epar-product-information_sv.pdf"
}See everything about zidovudine + abacavir sulfate + lamivudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.